Latest Breaking News On - ஸ்க்லரோடெர்மா ப்ரோக்ர்யாம் - Page 1 : comparemela.com
New Biomarkers May Predict Course of ILD in Systemic Sclerosis
medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
Lenabasum Missed Primary Endpoint for dcSSc but Isn t Dead Yet
medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
Repurposing an anti-inflammatory drug can prevent lung disease in patients with systemic sclerosis
news-medical.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news-medical.net Daily Mail and Mail on Sunday newspapers.
Spring Cleaning Tips for Fighting Inflammation Flare-Ups
healthcentral.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healthcentral.com Daily Mail and Mail on Sunday newspapers.
E-Mail
Scleroderma, a chronic and currently incurable orphan disease where tissue injury causes potentially lethal skin and lung scarring, remains poorly understood.
However, the defining characteristic of systemic sclerosis, the most serious form of scleroderma, is irreversible and progressive scarring that affects the skin and internal organs.
Published in We found that scleroderma inflammation dramatically increases CD38, an enzyme that normally breaks down a metabolic nutrient, NAD+. When NAD+ levels decrease, tissue injury becomes chronic and progresses to scar formation rather than to healthy repair, says study author John Varga, M.D., division chief of rheumatology at Michigan Medicine.
According to the study, treatments that prevented NAD+ reduction in the mice, whether by boosting the levels of the nutrient genetically or pharmacologically, prevented scarring in the skin, lungs and abdominal wall.